Peter Zhou

Peter Zhou is a seasoned finance professional with extensive experience in investment management and advisory roles. As Co-Founder and General Partner at Triatomic Capital since November 2020, Peter has been instrumental in shaping investment strategies. In addition to this role, Peter serves on the board of multiple organizations, including iPRONICS and ELEGEN, and has been a board member at the Cancer Research Institute since December 2015. Previous experience includes serving as Senior Managing Director at Coatue Management and a Private Equity Analyst at The Blackstone Group. Peter's foundational experience began at Morgan Stanley as a Summer Analyst. Peter holds a degree from Harvard University.